Allopurinol, dipyridamole and calcium channel blockers in the treatment of bipolar disorder – A nationwide cohort study

Adenosine modulators and calcium channel blockers as add-on treatment for schizophrenia

(2021) Jonne Lintunen et al.   npj Schizophrenia

Repurposed drugs as adjunctive treatments for mania and bipolar depression: A meta-review and critical appraisal of meta-analyses of randomized placebo-controlled trials

(2021) Francesco Bartoli et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Purinergic Signaling and Related Biomarkers in Depression

(2020) Francesco Bartoli et al.   Brain Sciences

Association of Hydroxylmethyl Glutaryl Coenzyme A Reductase Inhibitors, L-Type Calcium Channel Antagonists, and Biguanides With Rates of Psychiatric Hospitalization and Self-Harm in Individuals With Serious Mental Illness

(2019) Joseph F. Hayes et al.   JAMA Psychiatry

New drug candidates for bipolar disorder – A nation‐wide population‐based study

(2019) Lars Vedel Kessing et al.   BIPOLAR DISORDERS

Genome-wide association study identifies 30 loci associated with bipolar disorder

(2019) Eli A. Stahl et al.   NATURE GENETICS

The Role of Adenosine Receptors in Mood and Anxiety Disorders

(2019) Dietrich van Calker et al.   JOURNAL OF NEUROCHEMISTRY

Allopurinol augmentation in acute mania: A meta-analysis of placebo-controlled trials

(2018) Alexander T. Chen et al.   JOURNAL OF AFFECTIVE DISORDERS

Drug repurposing: progress, challenges and recommendations

(2018) Sudeep Pushpakom et al.   NATURE REVIEWS DRUG DISCOVERY

Purinergic system in psychiatric diseases

(2017) A Cheffer et al.   MOLECULAR PSYCHIATRY

CACNA1C polymorphism and altered phosphorylation of tau in bipolar disorder

(2016) Joel Jakobsson et al.   BRITISH JOURNAL OF PSYCHIATRY

Anxiety symptoms in a major mood and schizophrenia spectrum disorders

(2016) B. Karpov et al.   EUROPEAN PSYCHIATRY

Uric acid levels in subjects with bipolar disorder: A comparative meta-analysis

(2016) Francesco Bartoli et al.   JOURNAL OF PSYCHIATRIC RESEARCH

A systematic review of calcium channel antagonists in bipolar disorder and some considerations for their future development

(2016) A Cipriani et al.   MOLECULAR PSYCHIATRY

Agreement between PRE2DUP register data modeling method and comprehensive drug use interview among older persons

(2016) Heidi Taipale et al.   Clinical Epidemiology

Genetic disruption of voltage-gated calcium channels in psychiatric and neurological disorders

(2015) Samuel Heyes et al.   PROGRESS IN NEUROBIOLOGY

Allopurinol for mania: a randomized trial of allopurinol versus placebo as add-on treatment to mood stabilizers and/or antipsychotic agents in manic patients with bipolar disorder

(2014) Mark Weiser et al.   BIPOLAR DISORDERS

In a double-blind, randomized and placebo-controlled trial, adjuvant allopurinol improved symptoms of mania in in-patients suffering from bipolar disorder

(2014) Leila Jahangard et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Functional implications of a psychiatric risk variant within CACNA1C in induced human neurons

(2014) T Yoshimizu et al.   MOLECULAR PSYCHIATRY

Adenosine hypothesis in schizophrenia and bipolar disorder: A systematic review and meta-analysis of randomized controlled trial of adjuvant purinergic modulators

(2013) Tomoya Hirota et al.   SCHIZOPHRENIA RESEARCH

Allopurinol augmentation in the outpatient treatment of bipolar mania: a pilot study

(2012) Alexander Fan et al.   BIPOLAR DISORDERS

Medication for Attention Deficit–Hyperactivity Disorder and Criminality

(2012) Paul Lichtenstein et al.   NEW ENGLAND JOURNAL OF MEDICINE

Negative Controls

(2010) Marc Lipsitch et al.   EPIDEMIOLOGY

A Double-Blind, Randomized, Placebo-Controlled 4-Week Study on the Efficacy and Safety of the Purinergic Agents Allopurinol and Dipyridamole Adjunctive to Lithium in Acute Bipolar Mania

(2009) Rodrigo Machado-Vieira et al.   JOURNAL OF CLINICAL PSYCHIATRY